Authors:
Darcissac, ECA
Vidal, V
Guillaume, M
Thebault, JJ
Bahr, GM
Citation: Eca. Darcissac et al., Clinical tolerance and profile of cytokine induction in healthy volunteersfollowing the simultaneous administration of IFN-alpha and the synthetic immunomodulator murabutide, J INTERF CY, 21(9), 2001, pp. 655-661
Authors:
Zimmerman, H
Thebault, JJ
Duvauchelle, T
Mignot, A
Renoux, A
Gualano, V
Citation: H. Zimmerman et al., Pharmacokinetics of estradiol valerate 2mg+dienogest 2mg (Climodien (R) 2/2) after single and repeated oral administration in healthy postmenopausal women, CLIN DRUG I, 20(2), 2000, pp. 123-134
Authors:
Iacono, P
Velicitat, P
Guemas, E
Leclerc, V
Thebault, JJ
Citation: P. Iacono et al., Improved delivery of ipratropium bromide using Respimat (R) (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD, RESP MED, 94(5), 2000, pp. 490-495
Authors:
Zimmermann, H
Duvauchelle, T
Gualano, V
Kaufmann, G
Bervoas-Martin, S
Breitbarth, H
Mathieu, M
Mellinger, U
Ntsikoussalabongui, B
Oettel, M
Thebault, JJ
Citation: H. Zimmermann et al., Pharmacokinetics of dienogest as a single drug or in combination with estradiol valerate or ethinylestradiol, DRUGS TODAY, 35, 1999, pp. 27-39